PYC Therapeutics Ltd Total Assets

Latest as of June 2025: AU$183.28 Million AUD ≈ $129.68 Million USD

PYC Therapeutics Ltd total assets. Based on the latest financial reports, PYC Therapeutics Ltd (PYC) holds total assets worth AU$183.28 Million AUD (≈ $129.68 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see PYC company net worth for the company's overall valuation and market capitalisation.

Total Assets of PYC Therapeutics Ltd (2004–2025)

Total assets of PYC Therapeutics Ltd from 2004 to 2025. This chart illustrates how PYC Therapeutics Ltd's total assets have evolved over time, based on quarterly financial data. See PYC Therapeutics Ltd (PYC) stock price for real-time trading data and today's change.

PYC Therapeutics Ltd - Asset Composition Analysis

PYC Therapeutics Ltd Total Assets Breakdown (June 2025)

PYC Therapeutics Ltd total assets breakdown as of June 2025. PYC Therapeutics Ltd's total assets of AU$183.28 Million consist of 96.9% current assets and 3.1% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$153.05 Million	83.5%
Accounts Receivable	AU$24.07 Million	13.1%
Inventory	AU$0.00	0.0%
Property, Plant & Equipment	AU$1.90 Million	1.0%
Intangible Assets	AU$3.85 Million	2.1%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2004–2025)

This chart illustrates how PYC Therapeutics Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore PYC Therapeutics Ltd short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: PYC Therapeutics Ltd's current assets represent 96.9% of total assets in 2025, an increase from 0.0% in 2004.
Cash Position: Cash and equivalents constituted 83.5% of total assets in 2025, up from 67.4% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 28.0% in 2004.
Asset Diversification: The largest asset category is cash and equivalents at 83.5% of total assets.

PYC Therapeutics Ltd Competitors by Total Assets

Key competitors of PYC Therapeutics Ltd based on total assets are shown below.

Company	Country	Total Assets
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$11.72 Billion
HLB Co. Ltd KQ:028300	Korea	₩925.44 Billion
Tubize-Fin BR:TUB	Belgium	€1.99 Billion
Shanghai Medicilon Inc SHG:688202	China	CN¥2.88 Billion
Blue Jet Healthcare Limited NSE:BLUEJET	India	Rs16.41 Billion
Hangzhou Biotest Biotech Co Ltd SHG:688767	China	CN¥2.49 Billion
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	China	CN¥725.73 Million
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	China	CN¥3.67 Billion

PYC Therapeutics Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	14.41	9.40	36.23
Quick Ratio	14.41	11.38	36.23
Cash Ratio	12.43	7.34	10.26
Working Capital	AU$165.21 Million	AU$76.51 Million	AU$24.86 Million

PYC Therapeutics Ltd - Advanced Valuation Insights

This section examines the relationship between PYC Therapeutics Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	5.27
Latest Market Cap to Assets Ratio	4.33
Asset Growth Rate (YoY)	100.9%
Total Assets	AU$183.28 Million
Market Capitalization	$794.49 Million USD

Valuation Analysis

Premium Asset Valuation: The market values PYC Therapeutics Ltd's assets at a significant premium (4.33x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: PYC Therapeutics Ltd's assets grew by 100.9% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for PYC Therapeutics Ltd (2004–2025)

The table below shows the annual total assets of PYC Therapeutics Ltd from 2004 to 2025.

Year	Total Assets	Change
2025-06-30	AU$183.28 Million ≈ $129.68 Million	+100.88%
2024-06-30	AU$91.24 Million ≈ $64.56 Million	+145.49%
2023-06-30	AU$37.17 Million ≈ $26.30 Million	-18.05%
2022-06-30	AU$45.35 Million ≈ $32.09 Million	-21.73%
2021-06-30	AU$57.94 Million ≈ $41.00 Million	+83.67%
2020-06-30	AU$31.55 Million ≈ $22.32 Million	+370.75%
2019-06-30	AU$6.70 Million ≈ $4.74 Million	+96.00%
2018-06-30	AU$3.42 Million ≈ $2.42 Million	-66.96%
2017-06-30	AU$10.35 Million ≈ $7.32 Million	+42.42%
2016-06-30	AU$7.27 Million ≈ $5.14 Million	+306.85%
2015-06-30	AU$1.79 Million ≈ $1.26 Million	-60.53%
2014-06-30	AU$4.52 Million ≈ $3.20 Million	+99.97%
2013-06-30	AU$2.26 Million ≈ $1.60 Million	-35.27%
2012-06-30	AU$3.50 Million ≈ $2.47 Million	-38.26%
2011-06-30	AU$5.66 Million ≈ $4.01 Million	+260.57%
2010-06-30	AU$1.57 Million ≈ $1.11 Million	-54.98%
2009-06-30	AU$3.49 Million ≈ $2.47 Million	-0.90%
2008-06-30	AU$3.52 Million ≈ $2.49 Million	-0.42%
2007-06-30	AU$3.53 Million ≈ $2.50 Million	+24.78%
2006-06-30	AU$2.83 Million ≈ $2.00 Million	-53.45%
2005-06-30	AU$6.08 Million ≈ $4.31 Million	+418.27%
2004-06-30	AU$1.17 Million ≈ $830.68K	--

About PYC Therapeutics Ltd

AU:PYC Australia Biotechnology

Market Cap

$794.49 Million

AU$1.12 Billion AUD

Market Cap Rank

#9547 Global

#236 in Australia

Share Price

AU$1.88

Change (1 day)

-2.84%

52-Week Range

AU$1.07 - AU$2.91

All Time High

AU$2.91